Skip to Main Content

Paper Details

Clinical and radiographic response following targeting of BCAN-NTRK1 fusion in glioneuronal tumor.
NPJ Precis Oncol
49
2017
-, -NTRK1 fusion, 4th ventricular glioneuronal tumor, ALK, BCAN, BCAN exon 13, BRAF, BRAF mutations, Glioneuronal, Glioneuronal tumors, NTRK gene family, NTRK1, NTRK1 exon 11, ROS1, Trk, anaplastic, contrast, entrectinib, glioneuronal, glioneuronal tumor, glioneuronal tumors, lymphoma, lymphoma kinase, pan, patient, primary central nervous system neoplasms, tumors
Author NameAffiliation
Sun Ha PaekSeoul National University Hospital
Dora Dias-SantagataMassachusetts General Hospital, Harvard Medical School
Sandro SantagataBrigham & Women's Hospital, Harvard Medical School
Tracy T BatchelorMassachusetts General Hospital, Harvard Medical School
Tracy T BatchelorMassachusetts General Hospital, Harvard Medical School
Tracy T BatchelorMassachusetts General Hospital, Harvard Medical School
Tracy T BatchelorMassachusetts General Hospital, Harvard Medical School
Tracy T BatchelorMassachusetts General Hospital, Harvard Medical School
Tracy T BatchelorMassachusetts General Hospital, Harvard Medical School
Anthony J IafrateMassachusetts General Hospital, Harvard Medical School
Priscilla K BrastianosMassachusetts General Hospital, Harvard Medical School
Priscilla K BrastianosMassachusetts General Hospital, Harvard Medical School
  • 1 - 12

Datasets

Release 1.2